Dexamethasone Exerts Profound Immunologic Interference on Treatment Efficacy for Recurrent Glioblastoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy and Safety of Bevacizumab for the Treatment of Glioblastoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Autologous T-Cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

Cancer Research
Cancer ResearchOncology
2014English

Biochemical and Immunologic Predictors of Efficacy of Treatment or Reinfection Risk for Schistosoma Mansoni

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2006English

Profound Retroactive Interference in Anterograde Amnesia: What Interferes?

Neuropsychology
Physiological PsychologyNeuropsychology
2010English

Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of Α-Synuclein

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
2011English

Immunologic and Rheumatologic Causes and Treatment of Recurrent Pregnancy Loss: What Is the Evidence?

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2019English

Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2014English

Erratum To: Single-Agent Bevacizumab Is an Effective Treatment in Recurrent Glioblastoma

Medical Oncology
MedicineCancer ResearchOncologyHematology
2015English

Efficacy and Limitations of Stereotactic Radiosurgery in the Treatment of Glioblastoma

Neurologia Medico-Chirurgica
SurgeryNeurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy